Here, we use an autochthonous Braf/PTEN model of melanoma, modified to express OVA as a tumor-specific model antigen, to show that CD103+ TRM-like cells orchestrate the initial antitumor immune response and this response is antagonized by infiltration of regulatory T (Treg) cells. The gene discussed is ITGAE; the disease is neoplasm.